Valex CR 200 mg (Tablet (Controlled Release))
Unit Price: ৳ 6.00 (5 x 10: ৳ 300.00)
Strip Price: ৳ 60.00
Medicine Details
Category | Details |
---|---|
Generic | Sodium valproate |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Treatment of all types of epilepsy
- Prophylaxis of febrile convulsion
- Treatment of bipolar disorder
- Prophylaxis of migraine
Composition
- Enteric-coated tablet containing Sodium Valproate BP 200 mg
- Syrup containing Sodium Valproate BP 200 mg
- Controlled release tablet containing Sodium Valproate 200 mg as Sodium Valproate BP 133.2 mg & Valproic acid BP 58 mg
- Controlled release tablet containing Sodium Valproate 300 mg as Sodium Valproate BP 199.8 mg & Valproic acid BP 87 mg
- Controlled release tablet containing Sodium Valproate 500 mg as Sodium Valproate BP 333 mg & Valproic acid BP 145 mg
- Injectable solution containing Sodium Valproate BP eqv. to Valproic Acid 500 mg
Pharmacology
- Anti-epileptic activity against a variety of seizures
- Increase brain levels of gamma-aminobutyric acid (GABA)
Dosage & Administration
- Oral administration
- Initial dose for adults: 600 mg daily, increased by 200 mg/day at 3-day intervals
- Usual maintenance dose for adults: 1-2 g daily
- Initial dose for children (over 20 kg): 400 mg daily
- Maximum dose for children (over 20 kg): 35 mg/kg daily
- Initial dose for children (up to 20 kg): 20 mg/kg daily
- Febrile convulsion dosage: 20-30 mg/kg/day in 3 divided doses
- Bipolar disorder initial dosage: 600 mg daily, maintenance dosage: 1000-2000 mg daily
- Prophylaxis of migraine dosage: 400-600 mg daily, some may require 1000-1500 mg daily
- Injection administration for adults: usually 400-800 mg, followed by continuous or repeated infusion up to a maximum of 2500 mg/day
- Injection administration for children: Initial 20-30 mg/kg/day, maximum 40 mg/kg/day
Interaction
- Non-specific inhibitor of drug metabolism
- Significant interaction with Phenobarbital, Phenytoin, Warfarin, Aspirin
Contraindications
- Known hypersensitivity to the drug
- Liver dysfunction
- Restriction during pregnancy and in women of childbearing potential
Side Effects
- Anorexia
- Nausea
- Vomiting
- CNS effects: sedation, ataxia, tremor
- Rash
- Alopecia
- Stimulation of appetite
- Elevation of liver enzymes in plasma
- Fulminate hepatitis (rare)
- Hepatic injury in children below 2 years with other medical conditions
- Acute pancreatitis
- Hyperammonemia
Pregnancy & Lactation
- Crosses the placenta
- Associated with neural tube defects in newborn
- Excreted in breast milk
Precautions & Warnings
- Monitoring of liver functions before therapy and during first 6 months
- No undue potential for bleeding before starting and before major surgery
- Care should be taken in renal impairment, pregnancy, breast-feeding, and systemic lupus erythematosus
- Partially eliminated in the urine as a ketone metabolite, leading to false interpretation of the urine ketone test
- Sudden withdrawal of therapy should be avoided
Therapeutic Class
- Primary anti-epileptic drugs
Storage Conditions
- Do not store above 30°C
- Keep away from light and out of the reach of children
Related Brands
- Valoate 200 mg/5 ml (Syrup) - square-pharmaceuticals-plc
- Valex 200 mg/5 ml (Syrup) - incepta-pharmaceuticals-ltd
- Valex 200 mg (Tablet) - incepta-pharmaceuticals-ltd
- Epilim Chrono 500 mg (Tablet (Controlled Release)) - synovia-pharma-plc
- Epilim Chrono 300 mg (Tablet (Controlled Release)) - synovia-pharma-plc